Mochida Pharmaceutical Co., Ltd. (TYO:4534)

Japan · Delayed Price · Currency is JPY

3,285.00

+20.00 (0.61%)

Oct 23, 2026, 3:30 PM JST

Market Cap	115.38B +6.5%
Revenue (ttm)	122.04B +14.7%
Net Income	9.19B +52.5%
EPS	259.23 +52.5%
Shares Out	35.12M
PE Ratio	12.67
Forward PE	n/a
Dividend	85.00 (2.59%)
Ex-Dividend Date	Sep 29, 2026

Volume	51,400
Open	3,295.00
Previous Close	3,265.00
Day's Range	3,255.00 - 3,330.00
52-Week Range	2,929.00 - 3,965.00
Beta	0.08
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 9, 2026

About Mochida Pharmaceutical

Mochida Pharmaceutical Co., Ltd. manufactures and sells pharmaceuticals and healthcare products in Japan. The company offers pharmaceuticals products for the treatment of cardiovascular, obstetrics, gynecology, dermatologists, psychiatry, and gastroenterological, including Realda and Collagen for the treatment of ulcerative colitis; Goofis and Movicol for the treatment of chronic constipation; interstitial pulmonary hypertension for the treatment of pulmonary arterial hypertension; Treprospermid, for pulmonary hypertension associated with ulcer... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1913

Employees 1,479

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 4534

Full Company Profile

Financial Performance

In fiscal year 2026, Mochida Pharmaceutical's revenue was 116.95 billion, an increase of 11.21% compared to the previous year's 105.16 billion. Earnings were 7.90 billion, an increase of 39.01%.

Financial Statements